Align Technology | ALGN - Current Assets


Align Technology reported $2.66B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
3M USD 14.39B 1.99B Mar/2026
Align Technology USD 2.66B 38.87M Mar/2026
Becton, Dickinson and Co. USD 8.01B 1.18B Mar/2026
Bruker USD 2.1B 108.9M Mar/2026
Cardinal Health USD 38.06B 1.17B Mar/2026
Charles River Laboratories USD 1.49B 41.76M Mar/2026
Cooper Companies USD 2.3B 166M Mar/2026
CVS Health USD 74.82B 103M Mar/2026
Danaher USD 13.94B 1.18B Mar/2026
Dentsply International USD 1.85B 178M Mar/2026
Dexcom USD 4.33B 298.4M Mar/2026
Henry Schein USD 4.5B 32M Mar/2026
Idexx Laboratories USD 1.45B 40.25M Mar/2026
Insulet USD 1.71B 204.5M Mar/2026
Integra LifeSciences USD 1.17B 12.47M Mar/2026
IQVIA Holdings USD 6.22B 29M Mar/2026
McKesson USD 57.21B 2.49B Mar/2026
Mettler Toledo International USD 1.33B 30.76M Mar/2026
Revvity USD 2.13B 111.43M Mar/2026
Solventum Corp USD 3.58B 276M Mar/2026
Stryker USD 13.34B 1.42B Mar/2026
Teleflex USD 1.86B 78.67M Mar/2026
Thermo Fisher Scientific USD 22.32B 6.39B Mar/2026
Veeva Systems USD 8.06B 65.63M Mar/2026
Waters USD 3.72B 1.73B Mar/2026
Zimmer Biomet Holdings USD 4.96B 157.4M Mar/2026
Zoetis USD 6.47B 294M Mar/2026